New cancer clinical trial: Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer

Published on: July 31, 2018 at 12:00PM
Condition:   Colorectal Neoplasms, Malignant
Interventions:   Drug: Avelumab;   Drug: Cetuximab Injection;   Drug: Irinotecan
Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not yet recruiting
https://ift.tt/2Att12v